Jinglong Wang

3.3k total citations · 2 hit papers
24 papers, 2.7k citations indexed

About

Jinglong Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jinglong Wang has authored 24 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jinglong Wang's work include Epigenetics and DNA Methylation (4 papers), Cancer Mechanisms and Therapy (3 papers) and Chemokine receptors and signaling (3 papers). Jinglong Wang is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer Mechanisms and Therapy (3 papers) and Chemokine receptors and signaling (3 papers). Jinglong Wang collaborates with scholars based in China, United States and Australia. Jinglong Wang's co-authors include Rujia Zou, Meifang Zhu, Qiwei Tian, Shiping Yang, Zhigang Chen, Junqing Hu, Jianhua Wang, Feiran Jiang, Qian Liu and Jianhua Wang and has published in prestigious journals such as Advanced Materials, ACS Nano and Cancer Research.

In The Last Decade

Jinglong Wang

24 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hydrophilic Cu₉S₅ Nanocrystals: A Photothermal Agent with a 25.7% Heat Conversion Efficiency for Photothermal Ablation of Cancer Cells in Vivo

2011 1.2k citations Qiwei Tian, Rujia Zou et al. profile →
Hydrophilic Flower‐Like CuS Superstructures as an Efficient 980 nm Laser‐Driven Photothermal Agent for Ablation of Cancer Cells

2011 777 citations Qiwei Tian, Minghua Tang et al. Advanced Materials profile →

Peers

Countries citing papers authored by Jinglong Wang

Since Specialization

Citations

This map shows the geographic impact of Jinglong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinglong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinglong Wang more than expected).

Fields of papers citing papers by Jinglong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinglong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinglong Wang. The network helps show where Jinglong Wang may publish in the future.

Co-authorship network of co-authors of Jinglong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinglong Wang. A scholar is included among the top collaborators of Jinglong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinglong Wang. Jinglong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantitative proteomics profiling reveals the inhibition of trastuzumab antitumor efficacy by phosphorylated RPS6 in gastric carcinoma 2023 ·Cancer Chemotherapy and Pharmacology ·(unknown), (unknown), Jinglong Wang, Lidong Zu, Weiwei Shen, (unknown), Feng Gao, Liren Jiang, Stephen S.‐T. Yau, Guo‐Hui Fu	1
2	Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing 2023 ·Technology in Cancer Research & Treatment ·(unknown), Jinglong Wang, Ting Hou, (unknown), Lidong Zu, Guo‐Hui Fu, Weiwei Shen	1
3	A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules 2023 ·The Journal of Gene Medicine ·Dong Wang, Peng Li, (unknown), (unknown), Jinlong Li, Yunpeng Xuan, Jinglong Wang, (unknown), Weiqing Gu, (unknown)	3
4	An advanced non-small cell lung cancer patient with EGFR and KRAS mutations, and PD-L1 positive, benefited from immunotherapy: a case report 2022 ·Annals of Translational Medicine ·Ronghua Yang, Dong Wang, Xia Li, (unknown), Jinglong Wang, Peng Li, Xiaoliang Shi, Shanshan Zhang, Yongjie Wang	6
5	DDX54 Plays a Cancerous Role Through Activating P65 and AKT Signaling Pathway in Colorectal Cancer 2021 ·Frontiers in Oncology ·Yi Yu, Jinglong Wang, Lili Meng, (unknown), (unknown), Zhiping He, Xiaoqin Shi, Guo‐Hui Fu, Lidong Zu	16
6	Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer 2020 ·Journal of Experimental & Clinical Cancer Research ·Ya Cao, Jinglong Wang, Hua Tian, Guo‐Hui Fu	68
7	Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling 2018 ·BMC Cancer ·Lili Meng, Jinglong Wang, Shuping Xu, Lidong Zu, (unknown), Jianbing Zhang, Felicity Y. Han, Guo‐Hui Fu	11
8	Gastrin inhibits gastric cancer progression through activating the ERK-P65-miR23a/27a/24 axis 2018 ·Journal of Experimental & Clinical Cancer Research ·Lidong Zu, Xing‐Chun Peng, Zhi Zeng, Jinglong Wang, Lili Meng, Weiwei Shen, (unknown), Ye Yang, Guo‐Hui Fu	14
9	HIC1 loss promotes prostate cancer metastasis by triggering epithelial–mesenchymal transition 2017 ·The Journal of Pathology ·Mingang Hao, (unknown), Jinglong Wang, Jun Qin, Yingying Wang, Yufeng Ding, Min Jiang, Xueqing Sun, Lidong Zu, Kun Chang, Guowen Lin, (unknown), Vladimír Kořínek, (unknown), Jianhua Wang	23
10	The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasis 2016 ·Carcinogenesis ·Lidong Zu, Yunjing Xue, Jinglong Wang, Yujie Fu, Xiumin Wang, Gang Xiao, Mingang Hao, Xueqing Sun, Yingying Wang, Guo‐Hui Fu, Jianhua Wang	52
11	Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer 2016 ·Molecular Cancer ·Guangcun Cheng, Xuemei Fan, Mingang Hao, Jinglong Wang, Xiaoming Zhou, Xueqing Sun	71
12	USP2 promotes cell migration and invasion in triple negative breast cancer cell lines 2015 ·Tumor Biology ·(unknown), Yan Mao, Gang Xiao, Xiaochun Fei, Jinglong Wang, Yuzi Zhang, Junjun Liu, Guangcun Cheng, Xiaosong Chen, Jianhua Wang, Kunwei Shen	43
13	CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms 2015 ·Oncotarget ·Gang Xiao, Xiumin Wang, Jinglong Wang, Lidong Zu, Guangcun Cheng, Mingang Hao, Xueqing Sun, Yunjing Xue, Jinsong Lu, Jianhua Wang	71
14	PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients 2014 ·Cancer Immunology Immunotherapy ·(unknown), Xiaochun Fei, Yan Mao, Xiumin Wang, David Garfield, Ou Huang, Jinglong Wang, Fei Yuan, Long Sun, (unknown), Xiaolong Jin, Jianhua Wang, Kunwei Shen	130
15	HIC1 Modulates Prostate Cancer Progression by Epigenetic Modification 2013 ·Clinical Cancer Research ·Jianghua Zheng, Jinglong Wang, Xueqing Sun, Mingang Hao, Tao Ding, Dan Xiong, Xiumin Wang, (unknown), Gang Xiao, Guangcun Cheng, (unknown), Jian Zhang, Jianhua Wang	51
16	HIC1 Silencing in Triple-Negative Breast Cancer Drives Progression through Misregulation of LCN2 2013 ·Cancer Research ·Guangcun Cheng, Xueqing Sun, Jinglong Wang, Gang Xiao, Xiumin Wang, Xuemei Fan, Lidong Zu, Mingang Hao, Qing Qu, Yan Mao, Yunjing Xue, Jianhua Wang	50
17	Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer 2013 ·Molecular Cancer Research ·Xiaosong Chen, (unknown), Mingang Hao, Xueqing Sun, Jinglong Wang, Yan Mao, Lidong Zu, Junjun Liu, Yandong Shen, Jianhua Wang, Kunwei Shen	36
18	Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression 2012 ·Cancer Microenvironment ·Jianghua Zheng, Dan Xiong, Xueqing Sun, Jinglong Wang, Mingang Hao, Tao Ding, Gang Xiao, Xiumin Wang, Yan Mao, (unknown), Kunwei Shen, Jianhua Wang	25
19	Role of chemokine receptor CXCR7 in bladder cancer progression 2012 ·Biochemical Pharmacology ·Mingang Hao, Jianghua Zheng, (unknown), Jinglong Wang, Xiaosong Chen, (unknown), (unknown), Xu Chen, Kunwei Shen, Jianhua Wang	73
20	Hydrophilic Flower‐Like CuS Superstructures as an Efficient 980 nm Laser‐Driven Photothermal Agent for Ablation of Cancer Cells breakdown → 2011 ·Advanced Materials ·Qiwei Tian, Minghua Tang, Yangang Sun, Rujia Zou, Zhigang Chen, Meifang Zhu, Shiping Yang, Jinglong Wang, Jianhua Wang, Junqing Hu	777

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact